We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Risperidone Augmentation in Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00289861
Recruitment Status : Completed
First Posted : February 10, 2006
Last Update Posted : October 31, 2013
Stanley Medical Research Institute
Information provided by (Responsible Party):
Oliver Freudenreich, Massachusetts General Hospital